OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) has not experienced a meaningful mortality improvement for the past few decades. Successful screening is difficult to accomplish because most PDACs present late in their natural history, and current interventions have not provided significant benefit. Our goal was to identify determinants of survival for early PDAC to help inform future screening strategies. METHODS: Early PDACs from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program database (2000-2010) were analyzed. We stratified by size and included carcinomas in situ (Tis). Overall cancer-specific survival was calculated. A Cox proportional hazards model was developed and the significance of key covariates for survival prediction was evaluated. RESULTS: A Kaplan-Meier plot demonstrated significant differences in survival by size at diagnosis; these survival benefits persisted after adjustment for key covariates in the Cox proportional hazards analysis. In addition, relatively weaker predictors of worse survival included older age, male sex, black race, nodal involvement, tumor location within the head of the pancreas, and no surgery or radiotherapy. CONCLUSIONS: For early PDAC, we found tumor size to be the strongest predictor of survival, even after adjustment for other patient characteristics. Our findings suggest that early PDAC detection can have clinical benefit, which has positive implications for future screening strategies.
OBJECTIVES:Pancreatic ductal adenocarcinoma (PDAC) has not experienced a meaningful mortality improvement for the past few decades. Successful screening is difficult to accomplish because most PDACs present late in their natural history, and current interventions have not provided significant benefit. Our goal was to identify determinants of survival for early PDAC to help inform future screening strategies. METHODS: Early PDACs from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program database (2000-2010) were analyzed. We stratified by size and included carcinomas in situ (Tis). Overall cancer-specific survival was calculated. A Cox proportional hazards model was developed and the significance of key covariates for survival prediction was evaluated. RESULTS: A Kaplan-Meier plot demonstrated significant differences in survival by size at diagnosis; these survival benefits persisted after adjustment for key covariates in the Cox proportional hazards analysis. In addition, relatively weaker predictors of worse survival included older age, male sex, black race, nodal involvement, tumor location within the head of the pancreas, and no surgery or radiotherapy. CONCLUSIONS: For early PDAC, we found tumor size to be the strongest predictor of survival, even after adjustment for other patient characteristics. Our findings suggest that early PDAC detection can have clinical benefit, which has positive implications for future screening strategies.
Authors: L Tabár; B Vitak; H H Chen; S W Duffy; M F Yen; C F Chiang; U B Krusemo; T Tot; R A Smith Journal: Radiol Clin North Am Date: 2000-07 Impact factor: 2.303
Authors: Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur Journal: Radiology Date: 2014-11-12 Impact factor: 11.105
Authors: Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian Journal: Cancer Res Date: 2014-06-01 Impact factor: 12.701
Authors: Marcia Irene Canto; Ralph H Hruban; Elliot K Fishman; Ihab R Kamel; Richard Schulick; Zhe Zhang; Mark Topazian; Naoki Takahashi; Joel Fletcher; Gloria Petersen; Alison P Klein; Jennifer Axilbund; Constance Griffin; Sapna Syngal; John R Saltzman; Koenraad J Mortele; Jeffrey Lee; Eric Tamm; Raghunandan Vikram; Priya Bhosale; Daniel Margolis; James Farrell; Michael Goggins Journal: Gastroenterology Date: 2012-01-12 Impact factor: 22.682
Authors: Andrew D Rhim; Fredrik I Thege; Steven M Santana; Timothy B Lannin; Trisha N Saha; Shannon Tsai; Lara R Maggs; Michael L Kochman; Gregory G Ginsberg; John G Lieb; Vinay Chandrasekhara; Jeffrey A Drebin; Nuzhat Ahmad; Yu-Xiao Yang; Brian J Kirby; Ben Z Stanger Journal: Gastroenterology Date: 2013-12-13 Impact factor: 22.682
Authors: Alison P Klein; Sara Lindström; Julie B Mendelsohn; Emily Steplowski; Alan A Arslan; H Bas Bueno-de-Mesquita; Charles S Fuchs; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Andrea Lacroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Gloria M Petersen; Harvey A Risch; Rachael Z Stolzenberg-Solomon; Wei Zheng; Laufey Amundadottir; Demetrius Albanes; Naomi E Allen; William R Bamlet; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Eric J Duell; Joanne Elena; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Manal Hassan; Amy Hutchinson; David J Hunter; Charles Kooperberg; Robert C Kurtz; Simin Liu; Kim Overvad; Domenico Palli; Alpa V Patel; Kari G Rabe; Xiao-Ou Shu; Nadia Slimani; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Paolo Vineis; Jarmo Virtamo; Jean Wactawski-Wende; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Stephen J Chanock; Robert N Hoover; Patricia Hartge; Peter Kraft Journal: PLoS One Date: 2013-09-13 Impact factor: 3.240
Authors: David T Ting; Ben S Wittner; Matteo Ligorio; Nicole Vincent Jordan; Ajay M Shah; David T Miyamoto; Nicola Aceto; Francesca Bersani; Brian W Brannigan; Kristina Xega; Jordan C Ciciliano; Huili Zhu; Olivia C MacKenzie; Julie Trautwein; Kshitij S Arora; Mohammad Shahid; Haley L Ellis; Na Qu; Nabeel Bardeesy; Miguel N Rivera; Vikram Deshpande; Cristina R Ferrone; Ravi Kapur; Sridhar Ramaswamy; Toshi Shioda; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber Journal: Cell Rep Date: 2014-09-18 Impact factor: 9.423
Authors: Maryam A L Eissa; Lane Lerner; Eihab Abdelfatah; Nakul Shankar; Joseph K Canner; Nesrin M Hasan; Vesal Yaghoobi; Barry Huang; Zachary Kerner; Felipe Takaesu; Christopher Wolfgang; Ruby Kwak; Michael Ruiz; Matthew Tam; Thomas R Pisanic; Christine A Iacobuzio-Donahue; Ralph H Hruban; Jin He; Tza-Huei Wang; Laura D Wood; Anup Sharma; Nita Ahuja Journal: Clin Epigenetics Date: 2019-04-05 Impact factor: 6.551
Authors: Denise Wolrab; Robert Jirásko; Eva Cífková; Marcus Höring; Ding Mei; Michaela Chocholoušková; Ondřej Peterka; Jakub Idkowiak; Tereza Hrnčiarová; Ladislav Kuchař; Robert Ahrends; Radana Brumarová; David Friedecký; Gabriel Vivo-Truyols; Pavel Škrha; Jan Škrha; Radek Kučera; Bohuslav Melichar; Gerhard Liebisch; Ralph Burkhardt; Markus R Wenk; Amaury Cazenave-Gassiot; Petr Karásek; Ivo Novotný; Kristína Greplová; Roman Hrstka; Michal Holčapek Journal: Nat Commun Date: 2022-01-10 Impact factor: 17.694
Authors: Tessa Y S Le Large; Laura L Meijer; Elisa Giovannetti; Geert Kazemier; Rosita Paleckyte; Lenka N C Boyd; Bart Kok; Thomas Wurdinger; Tim Schelfhorst; Sander R Piersma; Thang V Pham; Nicole C T van Grieken; Barbara M Zonderhuis; Freek Daams; Hanneke W M van Laarhoven; Maarten F Bijlsma; Connie R Jimenez Journal: Oncologist Date: 2020-01-14